Access cutting-edge sickle cell disease treatment through this clinical trial at a research site in Boston. Study-provided care at no cost to qualified participants.
Access sickle cell disease specialists in Boston at no cost
This study follows strict safety protocols and ethical guidelines
All study-related sickle cell disease treatment provided free
This is an open-label, single-arm, multicenter, Phase 1/2 study evaluating the safety and efficacy of the administration of autologous base edited CD34+ HSPCs (BEAM-101) in patients with severe SCD
Sponsor: Beam Therapeutics Inc.
Check if you qualify for this sickle cell disease clinical trial in Boston, MA
If you're searching for sickle cell disease treatment options in Boston, MA, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Boston research site is actively enrolling participants for this clinical trial. You'll receive care from experienced sickle cell disease specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.